51 Jim Simons Gilead Sciences Trades
Jim Simons's position in Gilead Sciences is currently worth $278M. That's 0.38% of their equity portfolio (32nd largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Jim Simons bought shares 24 more times and sold shares on 26 occasions. The stake costed the investor $160M, netting the investor a gain of 74% so far.
Avg closing price
Price range
Sold 22.8% shares (-636k shares)
Q1 2026
Avg closing price
$140.42
Price range
$118.30
-
$155.80
Sold 49.0% shares (-2.67M shares)
Q4 2025
Avg closing price
$121.62
Price range
$110.56
-
$128.07
Sold 3.6% shares (-204k shares)
Q3 2025
Avg closing price
$113.63
Price range
$108.22
-
$120.47
Increased shares by 3.9% (+215k shares)
Q2 2025
Avg closing price
$106.47
Price range
$96.91
-
$113.00
Increased shares by 2.3% (+121k shares)
Q1 2025
Avg closing price
$102.80
Price range
$89.14
-
$117.41
Increased shares by 27.2% (+1.14M shares)
Q4 2024
Avg closing price
$90.22
Price range
$83.94
-
$97.90
Sold 17.2% shares (-869k shares)
Q3 2024
Avg closing price
$76.20
Price range
$66.59
-
$83.99
Increased shares by 17.1% (+740k shares)
Q2 2024
Avg closing price
$66.73
Price range
$63.15
-
$72.88
Sold 22.6% shares (-1.26M shares)
Q1 2024
Avg closing price
$76.90
Price range
$71.58
-
$87.29
Sold 13.5% shares (-868k shares)
Q4 2023
Avg closing price
$77.82
Price range
$73.27
-
$83.09
Sold 17.2% shares (-1.34M shares)
Q3 2023
Avg closing price
$76.92
Price range
$73.94
-
$80.67
Sold 26.5% shares (-2.8M shares)
Q2 2023
Avg closing price
$79.75
Price range
$76.01
-
$86.70
Increased shares by 15.0% (+1.38M shares)
Q1 2023
Avg closing price
$82.82
Price range
$77.31
-
$88.08
Sold 8.2% shares (-820k shares)
Q4 2022
Avg closing price
$79.19
Price range
$62.32
-
$89.47
Sold 25.3% shares (-3.39M shares)
Q3 2022
Avg closing price
$63.06
Price range
$59.54
-
$68.01
Sold 13.4% shares (-2.08M shares)
Q2 2022
Avg closing price
$61.91
Price range
$57.72
-
$65.01
Increased shares by 70.6% (+6.41M shares)
Q1 2022
Avg closing price
$63.92
Price range
$57.92
-
$72.58
Increased shares by 65.1% (+3.58M shares)
Q4 2021
Avg closing price
$68.88
Price range
$64.88
-
$73.64
Increased shares by 9.0% (+454k shares)
Q3 2021
Avg closing price
$70.25
Price range
$67.69
-
$73.03
Sold 23.1% shares (-1.51M shares)
Q2 2021
Avg closing price
$66.77
Price range
$63.47
-
$69.35
News about Gilead Sciences, Inc. and Jim Simons
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks. Click to skip ahead and see Jim Simons Stock Portfolio: 5 Biggest...
Jim Simons ''The Man Who Solved The Market'' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Cir...